H. Lundbeck A/S
H. Lundbeck A/S engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally. The company offers Abilify Maintena/ Abilify Asimtufii for schizophrenia and bipolar I disorder in adults; Brintellix/Trintellix to treat depressive disorders; Rexulti/Rxulti to treat maj… Read more
Market Cap & Net Worth: H. Lundbeck A/S (HLBBF)
H. Lundbeck A/S (PINK:HLBBF) has a market capitalization of $3.85 Billion ($3.85 Billion) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #5879 globally and #3395 in its home market, demonstrating a -16.66% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying H. Lundbeck A/S's stock price $4.85 by its total outstanding shares 793128424 (793.13 Million).
H. Lundbeck A/S Market Cap History: 2022 to 2025
H. Lundbeck A/S's market capitalization history from 2022 to 2025. Data shows growth from $2.87 Billion to $3.85 Billion (1.59% CAGR).
H. Lundbeck A/S Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how H. Lundbeck A/S's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.16x
H. Lundbeck A/S's market cap is 0.16 times its annual revenue
1.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
1.21x
H. Lundbeck A/S's market cap is 1.21 times its annual earnings
10.29x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $2.87 Billion | $18.25 Billion | $1.92 Billion | 0.16x | 1.50x |
| 2023 | $3.73 Billion | $19.91 Billion | $2.29 Billion | 0.19x | 1.63x |
| 2024 | $4.84 Billion | $22.00 Billion | $3.14 Billion | 0.22x | 1.54x |
| 2025 | $3.85 Billion | $24.30 Billion | $3.18 Billion | 0.16x | 1.21x |
Competitor Companies of HLBBF by Market Capitalization
Companies near H. Lundbeck A/S in the global market cap rankings as of March 18, 2026.
Key companies related to H. Lundbeck A/S by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
H. Lundbeck A/S Historical Marketcap From 2022 to 2025
Between 2022 and today, H. Lundbeck A/S's market cap moved from $2.87 Billion to $ 3.85 Billion, with a yearly change of 1.59%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $3.85 Billion | -20.51% |
| 2024 | $4.84 Billion | +29.87% |
| 2023 | $3.73 Billion | +29.81% |
| 2022 | $2.87 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of H. Lundbeck A/S was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.85 Billion USD |
| MoneyControl | $3.85 Billion USD |
| MarketWatch | $3.85 Billion USD |
| marketcap.company | $3.85 Billion USD |
| Reuters | $3.85 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.